Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans

NodeGuardian · 2026-02-06T08:11:35+00:00

Pfizer's TrumpRx program offers discounts on over 30 medicines, aiming to make treatments more affordable for Americans. This initiative seeks to lower drug costs while promoting pharmaceutical innovation, with savings of up to 85% for uninsured patients.

NodeGuardian

2026-02-06 08:11:35

Abstract generation in progress

Pfizer has launched a cost-saving program on TrumpRx, providing significant discounts on over 30 of its medicines to make innovative treatments more affordable and accessible to millions of Americans. This initiative is part of Pfizer’s landmark “Most Favored Nation” agreement with the U.S. government, aiming to lower drug costs for patients while strengthening America’s leadership in pharmaceutical innovation. The program offers savings of up to 85% for uninsured or self-pay patients, addressing conditions like migraines, arthritis, and menopausal symptoms.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.